So far, a number of recent studies focused on pathophysiological mechanism and/or potential therapeutic strategy to modulate inflammatory and oxidative stress pathways involving NLRP3 inflammasome in stroke brain damage (Figure 1). The gene discussed is NLRP3; the disease is stroke disorder.